When motor neurons damaged by amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, inappropriately send the wrong signal, immune cells react by killing the messenger. Their surprising finding provides new direction for therapies to treat ALS.
The study was conducted in the laboratory of Don Cleveland, Ph.D., UCSD Professor of Medicine, Neurosciences and Cellular and Molecular Medicine and member of the Ludwig Institute for Cancer Research and will be published online April 27 in advance of publication in the journal Proceedings of the National Academy of Sciences.